UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Purinergic signalling and disorders of the central nervous system

Burnstock, G; (2008) Purinergic signalling and disorders of the central nervous system. NAT REV DRUG DISCOV , 7 (7) 575 - 590. 10.1038/nrd2605.

Full text not available from this repository.

Abstract

Purines have key roles in neurotransmission and neuromodulation, with their effects being mediated by the purine and pyrimidine receptor subfamilies, P1, P2X and P2Y. Recently, purinergic mechanisms and specific receptor subtypes have been shown to be involved in various pathological conditions including brain trauma and ischaemia, neurodegenerative diseases involving neuroimmune and neuroinflammatory reactions, as well as in neuropsychiatric diseases, including depression and schizophrenia. This article reviews the role of purinergic signalling in CNS disorders, highlighting specific purinergic receptor subtypes, most notably A(2A), P2X(4) and P2X(7), that might be therapeutically targeted for the treatment of these conditions.

Type:Article
Title:Purinergic signalling and disorders of the central nervous system
DOI:10.1038/nrd2605
Keywords:ADENOSINE A(2A) RECEPTORS, EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, TRANSIENT FOREBRAIN ISCHEMIA, ALZHEIMERS-DISEASE PATIENTS, ACTIVATED PROTEIN-KINASE, CORTEX KINDLED SEIZURES, TEMPORAL-LOBE EPILEPSY, TRANSGENIC MOUSE MODEL, RAT HIPPOCAMPAL SLICES, SPINAL-CORD-INJURY
UCL classification:UCL > School of Life and Medical Sciences > Faculty of Life Sciences > Biosciences (Division of)

Archive Staff Only: edit this record